Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Litron Laboratories Ltd
- Proposal award date
- 2020-09-25
- Contract end date
- 2021-08-31
- UEI
- LJH7LE9AUHL5
- Solicitation number
- ES20-005
- Topic code
- R
Research abstract
Project Summary
Studying cells in simple 2D culture systems has many advantages with of ease of use,
ability to screen many conditions in a short amount of time, targeted addition or deletion
of genes, proteins or other components and focused study of specific pathways
representing only a few. However, that simplicity can also lead to loss of key functions
and an overall lack of relevancy to whole organisms, especially humans. In an effort to
bridge this gap between cells in a dish and a human being, in vitro models are being
developed that mimic the function of whole organs, so-called organotypic cultures.
These models represent an opportunity to study highly complex, multicellular systems
that will respond more like actual organs as opposed to cells grown in a simple
monolayer. Our studies will develop a model of rat liver cells grown in a 3-dimensional
format and pair that with an efficient, high-content analytical platform that will provide
information on DNA function and cell health. The value of these types of models is
significant for both basic science and more targeted research efforts such as human
safety studies. Assessment of the safety of compounds like drug candidates, industrial
chemicals and consumer products relies on preclinical test models to report useful
information of human safety. The ability of cell-based models to do this is often
challenged when the in vitro and in vivo systems lack sufficient relevancy to the human
condition. The proposed 3D organ models may overcome existing limitations and result
in lower costs while providing better information. The combination of data-rich assays
that enable fast and efficient assessment of in vitro animal-derived organ models
represents an opportunity to improve safety testing and create tools that will benefit
numerous other research initiatives that rely on in vitro systems.Project Narrative
Recent advances in cell culture have lead to the development of highly complex
miniaturized tissue systems that replicate the function of human organs.
The use of more relevant animal-derived organ models and the development of tools to
better assess their responses could greatly improve chemical/drug safety studies, as
well as aid in discoveries made in the basic sciences. This project seeks to create novel
assays that can be used to provide quantitative information on activity and toxicological
responses of complex 3D liver models to improve the relevancy and efficacy of these
important in vitro organ systems.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
42 SBIR/STTR records share this UEI (1985–2025). Reported award amounts total $18,400,554. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards